CAPLIPOINT.BO BSE
Caplin Point Laboratories Ltd.
1W: -8.2%
1M: -3.1%
3M: +3.8%
YTD: +52.0%
₹2,634.00 ($27.35)
-74.80 (-2.76%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$40.5B
+26.1% ▲
Total Liabilities
$4.1B
+28.7% ▲
Shareholders Equity
$35.9B
+25.8% ▲
Cash & Investments
$10.1B
+11.5% ▲
Total Debt
$46M
-8.2% ▼
Net Debt
-$6.2B
-5.1% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2025 | FY2026 |
|---|---|---|
| — Assets — | ||
| Cash | $5.9B | $6.2B |
| Short-Term Investments | $3.1B | $3.9B |
| Cash & ST Investments | $9.0B | $10.1B |
| Net Receivables | $6.3B | $8.3B |
| Inventory | $3.4B | $4.3B |
| Other Current Assets | $2.6B | $3.2B |
| Total Current Assets | $21.3B | $25.9B |
| Property, Plant & Equip. | $6.7B | $7.6B |
| Goodwill & Intangibles | $156M | $538M |
| Long-Term Investments | $2.8B | $5.0B |
| Other Non-Current Assets | $1.1B | $1.4B |
| Total Non-Current Assets | $10.7B | $14.6B |
| Total Assets | $32.1B | $40.5B |
| — Liabilities — | ||
| Accounts Payable | $2.2B | $3.0B |
| Short-Term Debt | $6M | $6M |
| Deferred Revenue | $0 | $0 |
| Other Current Liabilities | $627M | $874M |
| Total Current Liabilities | $3.1B | $3.9B |
| Long-Term Debt | $0 | $0 |
| Other Non-Current Liab. | $125M | $141M |
| Total Non-Current Liabilities | $158M | $287M |
| Total Liabilities | $3.2B | $4.1B |
| — Equity — | ||
| Common Stock | $152M | $152M |
| Retained Earnings | $23.8B | $0 |
| Accumulated OCI | $2.2B | $35.0B |
| Total Stockholders Equity | $28.5B | $35.9B |
| Total Liabilities & Equity | $32.1B | $40.5B |
| — Key Metrics — | ||
| Total Debt | $50M | $46M |
| Net Debt | -$5.9B | -$6.2B |
| Total Investments | $5.9B | $8.9B |